- Email: [email protected]
21
S4
JO U R N A L OF GE RI A TR IC O N C O LOG Y 3 ( 20 1 2 ) S 1 – S9
evaluation of the significance of Single Nucleotide Polymorphisms in the development of cancer cachexia3.
from the Cancer and Aging Research Group, which Dr. Hurria founded and leads.
1. http://phdtheses.ekt.gr/eadd/handle/10442/25097 2. Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history. Gioulbasanis I, Baracos VE, Giannousi Z, et al. Ann Oncol. 2011 Apr;22(4):835-41. 3. Selecting for predisposition to cancer cachexia. Gioulbasanis I, Vlachostergios PJ, Papandreou CN. EMBO Mol Med. 2012 Jun; 4(6):451-2. http://dx.doi.org/10.1002/emmm.201200232.
doi:10.1016/j.jgo.2012.09.124
doi:10.1016/j.jgo.2012.09.122
Margot Gosney Clinical Health Sciences, University of Reading, Reading, Berkshire, UK Professor Margot Gosney began her studies in medicine at the University of Liverpool. She decided on a career in Geriatric Medicine during her undergraduate days and spent her final year elective researching adverse drug reactions and potential interactions in elderly hospitalised people. This resulted in her first publication in The Lancet. In 1992, she was appointed Senior Lecturer at the University of Liverpool, in 2003 appointed Chair of Elderly Care Medicine at the University of Reading. She has published extensively in oncology, nutrition and influenza. She advises the European Society of Surgical Oncology (ESSO) and International Society of Geriatric Oncology (SIOG), on the involvement of older people in oncology trials and the development of guidelines for the investigation and management of older people with colorectal cancer. She is running one of five pilot sites, funded by the Department of Health and Macmillan Cancer Care, focusing on the care of older people with cancer. She is researching the barriers to good nutrition and strategies to improve this with a multidisciplinary group, including world renowned chefs. Her research predominantly focuses on hospitalised individuals at most risk of the results of suboptimal nutrition, but has included assessment of taste thresholds and flavour favourites in healthy older people.
Syed Md Akram Hussain Lab Aid Specialized Hospital Adviser, Women Cancer & Other NCD Screening Program, AK Khan Healthcare Trust Founder Chairman, Department of Oncology Bangabandhu Sheikh Mujib Medical University, Former National Consultant, Cancer and other NCD World Health Organization, Dhaka, Bangladesh Professor Syed Md Akram Hussain was awarded MBBS from University of Dhaka, FCPS from Bangladesh College of Physicians and Surgeons (BCPS), FRCP from Royal College of Physicians and Surgeons of Glasgow and Royal College of Physicians of Edinburgh, FACP from American College of Physicians and MPH from ADUST. He began career at National Institute of Cancer Research since 1993 and hold different positions. He joined the premier Institute of the country Bangabandhu Sheikh Mujib Medical University (BSMMU) as a Professor of Oncology and Chairman of the Department of Oncology in 2006. He has been a teacher of oncology for twenty years and supervises faculties, residents and developed curriculum. He is an examiner of Membership and Fellowship examination of BCPS and MPhil, MD & PhD examination of BSMMU and other universities. He is involved in various collaborative and multi-national research activities. He has 85 publications published in different peer reviewed national and international indexed journals. He has edited National Cancer Control Strategy, National Non-Communicable Disease (NCD) Control strategy, National strategy for Tobacco Control of Bangladesh and SEANET-NCD Strategy published by WHO. He is a coauthor of a book on ‘Lung Cancer' published by TATA Memorial Hospital, India. He has delivered 100 plenary lectures at the national and international levels. He is interested in clinical, molecular research and public health research. He was the treasurer of Bangladesh oncology society, publicity secretary of Bangladesh Medical association. He is the national representative of SIOG for Bangladesh. He is a councilor of the Asian Society of Clinical Oncology and an active member of ESMO and ASCO. He actively participated in the High level UN Meeting on NCD in 2011.
doi:10.1016/j.jgo.2012.09.123 doi:10.1016/j.jgo.2012.09.125 Arti Hurria Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA, USA Department of Population Sciences, City of Hope, Duarte, CA, USA Arti Hurria, MD is a geriatrician and oncologist, focusing on care of the older patient with cancer. She completed a geriatric fellowship in the Harvard Geriatric Fellowship Program, followed by a hematology– oncology fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC). She subsequently joined the faculty at MSKCCC, where she served as co-Principal Investigator on the institutional NIH P20 grant “Development of an Aging and Cancer Center at MSKCC.” In the fall of 2006 Dr. Hurria joined the City of Hope as Director of the Cancer and Aging Research Program. Dr. Hurria is a recipient of the Paul Beeson Career Development Award in Aging Research (K23 AG026749-01) and American Society of Clinical Oncology-Association of Specialty Professors-Junior Development Award in Geriatric Oncology, and vice co-chair of the Alliance Cancer in the Elderly Committee. Dr. Hurria serves a PI on a U13 grant in collaboration with the NIA and NCI to identify and develop research methodology that will lead evidence based recommendations to improve clinical care for older adults with cancer. She also serves as PI on an R01 funded grant evaluating clinical and biological predictors of chemotherapy toxicity in older adults with breast cancer. These grants are executed in collaboration with members
Maryska Janssen-Heijnen Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, The Netherlands Dr. Maryska Janssen-Heijnen has been working as a senior epidemiologist at the Eindhoven Cancer Registry in the Netherlands, where she has focused on prognostic factors for cancer patients, with a special interest in elderly patients with comorbidity. Since 2000 she has been coordinating large population-based projects in which the prevalence of comorbidity in cancer patients is studied, as well as the influence of increasing age and comorbidity on treatment, complications of treatment and prognosis. Since 2010 she has been working as a clinical epidemiologist at VieCuri Medical Centre Venlo, a large teaching hospital in the Netherlands. One of her main research topics is cancer in the elderly and multimorbidity. doi:10.1016/j.jgo.2012.09.126
Cindy Kenis University Hospitals Leuven, Belgium Cindy Kenis is a geriatric oncology nurse working at the University Hospitals Leuven in Belgium. She graduated as a registered nurse at
JO U R N A L OF GE RI A TR IC O N C O LOG Y 3 ( 20 1 2 ) S 1 – S9
evaluation of the significance of Single Nucleotide Polymorphisms in the development of cancer cachexia3.
from the Cancer and Aging Research Group, which Dr. Hurria founded and leads.
1. http://phdtheses.ekt.gr/eadd/handle/10442/25097 2. Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history. Gioulbasanis I, Baracos VE, Giannousi Z, et al. Ann Oncol. 2011 Apr;22(4):835-41. 3. Selecting for predisposition to cancer cachexia. Gioulbasanis I, Vlachostergios PJ, Papandreou CN. EMBO Mol Med. 2012 Jun; 4(6):451-2. http://dx.doi.org/10.1002/emmm.201200232.
doi:10.1016/j.jgo.2012.09.124
doi:10.1016/j.jgo.2012.09.122
Margot Gosney Clinical Health Sciences, University of Reading, Reading, Berkshire, UK Professor Margot Gosney began her studies in medicine at the University of Liverpool. She decided on a career in Geriatric Medicine during her undergraduate days and spent her final year elective researching adverse drug reactions and potential interactions in elderly hospitalised people. This resulted in her first publication in The Lancet. In 1992, she was appointed Senior Lecturer at the University of Liverpool, in 2003 appointed Chair of Elderly Care Medicine at the University of Reading. She has published extensively in oncology, nutrition and influenza. She advises the European Society of Surgical Oncology (ESSO) and International Society of Geriatric Oncology (SIOG), on the involvement of older people in oncology trials and the development of guidelines for the investigation and management of older people with colorectal cancer. She is running one of five pilot sites, funded by the Department of Health and Macmillan Cancer Care, focusing on the care of older people with cancer. She is researching the barriers to good nutrition and strategies to improve this with a multidisciplinary group, including world renowned chefs. Her research predominantly focuses on hospitalised individuals at most risk of the results of suboptimal nutrition, but has included assessment of taste thresholds and flavour favourites in healthy older people.
Syed Md Akram Hussain Lab Aid Specialized Hospital Adviser, Women Cancer & Other NCD Screening Program, AK Khan Healthcare Trust Founder Chairman, Department of Oncology Bangabandhu Sheikh Mujib Medical University, Former National Consultant, Cancer and other NCD World Health Organization, Dhaka, Bangladesh Professor Syed Md Akram Hussain was awarded MBBS from University of Dhaka, FCPS from Bangladesh College of Physicians and Surgeons (BCPS), FRCP from Royal College of Physicians and Surgeons of Glasgow and Royal College of Physicians of Edinburgh, FACP from American College of Physicians and MPH from ADUST. He began career at National Institute of Cancer Research since 1993 and hold different positions. He joined the premier Institute of the country Bangabandhu Sheikh Mujib Medical University (BSMMU) as a Professor of Oncology and Chairman of the Department of Oncology in 2006. He has been a teacher of oncology for twenty years and supervises faculties, residents and developed curriculum. He is an examiner of Membership and Fellowship examination of BCPS and MPhil, MD & PhD examination of BSMMU and other universities. He is involved in various collaborative and multi-national research activities. He has 85 publications published in different peer reviewed national and international indexed journals. He has edited National Cancer Control Strategy, National Non-Communicable Disease (NCD) Control strategy, National strategy for Tobacco Control of Bangladesh and SEANET-NCD Strategy published by WHO. He is a coauthor of a book on ‘Lung Cancer' published by TATA Memorial Hospital, India. He has delivered 100 plenary lectures at the national and international levels. He is interested in clinical, molecular research and public health research. He was the treasurer of Bangladesh oncology society, publicity secretary of Bangladesh Medical association. He is the national representative of SIOG for Bangladesh. He is a councilor of the Asian Society of Clinical Oncology and an active member of ESMO and ASCO. He actively participated in the High level UN Meeting on NCD in 2011.
doi:10.1016/j.jgo.2012.09.123 doi:10.1016/j.jgo.2012.09.125 Arti Hurria Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA, USA Department of Population Sciences, City of Hope, Duarte, CA, USA Arti Hurria, MD is a geriatrician and oncologist, focusing on care of the older patient with cancer. She completed a geriatric fellowship in the Harvard Geriatric Fellowship Program, followed by a hematology– oncology fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC). She subsequently joined the faculty at MSKCCC, where she served as co-Principal Investigator on the institutional NIH P20 grant “Development of an Aging and Cancer Center at MSKCC.” In the fall of 2006 Dr. Hurria joined the City of Hope as Director of the Cancer and Aging Research Program. Dr. Hurria is a recipient of the Paul Beeson Career Development Award in Aging Research (K23 AG026749-01) and American Society of Clinical Oncology-Association of Specialty Professors-Junior Development Award in Geriatric Oncology, and vice co-chair of the Alliance Cancer in the Elderly Committee. Dr. Hurria serves a PI on a U13 grant in collaboration with the NIA and NCI to identify and develop research methodology that will lead evidence based recommendations to improve clinical care for older adults with cancer. She also serves as PI on an R01 funded grant evaluating clinical and biological predictors of chemotherapy toxicity in older adults with breast cancer. These grants are executed in collaboration with members
Maryska Janssen-Heijnen Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, The Netherlands Dr. Maryska Janssen-Heijnen has been working as a senior epidemiologist at the Eindhoven Cancer Registry in the Netherlands, where she has focused on prognostic factors for cancer patients, with a special interest in elderly patients with comorbidity. Since 2000 she has been coordinating large population-based projects in which the prevalence of comorbidity in cancer patients is studied, as well as the influence of increasing age and comorbidity on treatment, complications of treatment and prognosis. Since 2010 she has been working as a clinical epidemiologist at VieCuri Medical Centre Venlo, a large teaching hospital in the Netherlands. One of her main research topics is cancer in the elderly and multimorbidity. doi:10.1016/j.jgo.2012.09.126
Cindy Kenis University Hospitals Leuven, Belgium Cindy Kenis is a geriatric oncology nurse working at the University Hospitals Leuven in Belgium. She graduated as a registered nurse at